Perlen Packaging has expanded their European PVdC barrier film operations with the extension of their coating line in Perlen. Together with the construction of a manufacturing site in China, Perlen Packaging is investing more than $20 million in the extension of its global capacities for pharmaceutical films.

“The extension of the PVdC coating line in Perlen will allow for a more flexible and efficient production, as well as increasing the coating capacity,” said Johannes Giessler, director of sales and marketing, Perlen Packaging. “The pharma markets in Europe are continually growing and the demand for barrier films is increasing. Due to the continuous investments in our technology and our GMP standard production facilities in Germany and Switzerland, we can ensure the continued availability of our high-quality products for the European pharmaceutical market.”

Perlen Packaging offers high barrier PVdC films for blister packaging.

“We want to extend this position, as this special market segment will grow above average because of the increasing complexity of molecular structures and global distribution. As a consequence this requires additional coating capacity, which we are providing with this investment,” said Wolfgang Grimm, chief executive officer, Perlen Packaging.

Simultaneously Perlen Packaging is setting up a production facility for the Asian market. The groundbreaking ceremony for the new site took place in Wujiang, China in spring 2015 and the plant will be ready to deliver its first products during 2016.

“The Asian pharmaceutical markets are showing double-digit growth rates. As the first foreign company to set up a production facility in China, Perlen Packaging’s aim is to cater to the expected growth in the region and to better serve the markets from a local site,” said Mr. Grimm.

Overall, Perlen Packaging is investing more than $20 million in the extension of its production capacities in Europe and Asia.